Reduced expression of GLUT1 in 78617GL cells decreases glucose usage, lipid synthesis and proliferation in vitro. by Christian D. Young (211228)

Frequency homeostasis in the oscillator described in Fig 8. by Melissa Nygård (15374507)

miR-143 overexpression decreases human colon carcinoma cell tumor xenograft growth in nude mice. by Pedro M. Borralho (217909)

Angiotensin-(1-7) infusion reduces fibrosis and decreases ACE2 expression in <i>mdx</i> muscle. by Cecilia Riquelme (546116)

Figure 1 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

TNP increases while Gd³⁺ decreases BASIC activity in a dose-dependent manner. by Axel Schmidt (652713)

Disrupting actin stress fibers decreases [Ca²⁺]_i oscillation frequency. by Charles Godbout (540424)

“…Scale bar = 50 μm. B) Representative fluorescence ratio (Em₃₄₀/Em₃₈₀) of a Fura-2-loaded cell over time is shown. …”

Inhibition of HDAC6 activity decreased the levels of EGFR and increased acetyl-α-tubulin in renal epithelial cells. by Wei Liu (20030)

“…(E) and (F) TSA (200 ng/ml) has the same effect on the expression of EGFR and acetyl-α-tubulin in postnatal <i>Pkd1</i> heterozygous PH2 and homozygous PN24 cells. * <i>p < 0.05</i>. ** <i>p < 0.01</i>.…”

<i>In vitro</i> application of ARTN decreased ATF3 expression in GFRα3-positive neurons. by Ting Wang (16292)

“…Scale bar = 50 µm. Two way ANOVA, <i>p</i><0.01.</p>…”

Pacritinib effectively decreases BTIC viability and sphere forming capacity and has on-target activity on phospho-STAT3. by Katharine Victoria Jensen (4691530)

“…<p>(A) Pacritinib dramatically decreased cell viability in a dose dependent manner in eleven molecularly diverse patient-derived BTIC cultures with IC₅₀ values from 0.62 μM to 1.66 μM. …”

TSA administration decreases neuromuscular junction loss in <i>Smn^2B/-</i> mice. by Hong Liu (50694)

“…Note that whilst there is widespread NMJ pathology in vehicle treated mice, as evidence by full/partial denervation (white arrowhead/arrow respectively), NF accumulation (yellow arrow) and small, immature post-synaptic endplates, NMJs appear much more healthy in TSA treated mice, as evidenced by a decrease in denervation and NF accumulation, and an increase in post-synaptic size and maturity (scale bar = 50 µm). …”

Auditory Brainstem Responses (ABR) measurement revealed decreased conduction velocities in the offspring born to iron deficient dams. by Camelia Mihaila (354659)

Figure 7 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

“…Shown are data from one donor (<i>n</i> = 2). <b>E,</b> PD-L1 CAR T-cell cytotoxicity against luciferase-expressing PD-L1 knockout or PD-L1⁺ MDA-MB-231 cells in the presence of different concentrations of NH₄Cl. …”

Overexpression of <i>EVI1</i> decreases the sensitivity of U937 cells to drugs used in AML therapy. by Anna Rommer (241040)

MT treatment in the <i>in vivo</i> OS animal model decreased body weight and increased tumor size. by Jir-You Wang (117926)

“…The results showed that MT (+) group showed decreased body weight (E, 30.5±0.65 g, ▪) and increased tumor volume (F, 8.3±1.18 mm³, ▪) compared to MT (−) group with body weight (E, 35.8±0.40 g, □) and tumor volume (F, 3.9±1.34 mm³, □), respectively. (*, p<0.05 compare with MT (+) versus MT (−) groups).…”

Figure 6 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

RNS60 treatment of tMCAo mice decreased microglial activation in the CA3 region of the ipsilateral hippocampus. by Gloria Patricia Baena-Caldas (17721328)

VPA treated prostate cancer cells show decreased repair capacity and γ-H2AX clearance. by Sushant K. Kachhap (273170)

Colocalization of Sig1R-YFP in SK-OV-3 cells with the markers pmKate2-mito and KDEL-mRFP. by Sergei Kopanchuk (6406085)

EDN3 is associated with decreased levels of RA receptor mRNA and RA metabolic enzyme mRNA. by Jonathan M. Gisser (456149)